Portfolio Companies

CTTC owns equity in a diverse group of companies that span a range of technologies and industries including assistive exosuits, online education, computerized surgical navigation, nanotechnology, personalized medicine, clinical information management systems, clinical diagnostics, drug discovery, radiation therapy, and healthcare services. The Center’s active portfolio currently includes the following companies:

  • AbSeek Bio

    Providing Ab discovery, vaccine testing, and optimization services.
  • Abvance Therapeutics

    Innovative solutions to address unmet needs in diabetes care

  • Amytrx Therapeutics

    Biopharmaceutical Drug Development Company with Innovative Peptide-based Solutions for Inflammation and Metabolic Syndrome

  • Appello Pharmaceuticals, Inc.

    Focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.

  • Cumberland Emerging Technologies

    Life sciences business incubation

  • eFiber Innovations

    We manufacture nanofiber-based materials/devices that: (1) address critical needs, (2) exhibit unparalleled performance/durability and (3) are available commercially at a competitive cost.
  • FemtoMetrix

    Semiconductor materials

  • GenomOncology, LLC

    Enables the application of genomics in oncology to improve patient care

  • HeroWear, LLC

    HeroWear is designing a line of wearable technology that improves the safety, health, and productivity of workers in physically demanding jobs. Our first product is a lift assistance device that fits like clothing, while significantly offloading the low back muscles.

  • IDBiologics

    Discovery and development of human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.

  • International FemtoScience, Inc.

    Research & development for advanced technology

  • KaiNexus

    CQI software and services           

  • Metalytics

    Metalytics provides critical information about cellular metabolic rates in living cells, giving our clients actionable results they can implement to accelerate research, development, and manufacturing timelines.
  • Nashville Biosciences

    Leveraging real-world clinical and genomic data to advance the discovery and development of new, more personalized therapeutics and diagnostics.
  • nPhase

    Machine to machine wireless communications and services for healthcare, manufacturing, utilities, distribution, and consumer product industries.
  • Path Ex, Inc.

    PATH EX is an extracorporeal blood cleansing device designed to selectively remove bacteria, including multi-drug resistant strains, and endotoxin from circulating blood.

  • Pendant Biosciences

    Drug delivery system

  • Protypia

    Protypia analyzes the protein targets of oncology drugs and the protein pathways and networks in which they function. We use new mass spectrometry technology to quantitatively and precisely measure proteins.
  • SkyNano Technologies

    We focus on a low cost manufacturing technique of high value carbon materials, using only inexpensive materials, electricity, and carbon dioxide as direct inputs.
  • Synchromotion

    Synchro Motion’s vision is to become established as an industry leader in the design and control of rehabilitation robotics.
  • TyraTech (TYR.L)

    Natural insect control products

  • Universal Robotics

    Hardware-independent software engineering company specializing in machine learning

  • Virtuoso Surgical

    Transforming minimally invasive surgery by providing surgeons with dexterous, accurate, and cost-effective robotic tools through endoscopes.

  • VoluMetrix

    Developing a low-cost, non-invasive device that measures fluid status

  • Wavefront Biosciences

    Drug Discovery Tools